Posted by Shelly Janes on Apr 20th, 2024
Immunic (NASDAQ:IMUX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday.
Separately,...
More of this article »